Skip to content
Wenlo
Sign in
← Markets

Brainstorm Cell Therapeutics Inc.

Peter Joe Pitts (Executive Chairman) reports BCLI insider transactions

4BCLIFiled Jul 28, 2026, 1:00 PM ET· Period Jul 24, 2026

About this filing

Brainstorm Cell Therapeutics Inc. (BCLI) filed Form 4 (insider transaction) with the SEC on Jul 28, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Peter Joe Pitts · Executive Chairman, Director
DateTransactionSharesPriceValueHeld afterOwnership
Jul 24, 2026A · grantStock Option (Right to Buy)Footnotes F1, F2+900,000$0.00$0.00900,000Direct
Footnotes
  1. F1 Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
  2. F2 The stock options vest over 48 months, with 25% vesting on July 24, 2027 and 1/48th vesting monthly thereafter, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

More BCLI filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.